SB
Staidson Beijing Biopharma
🇨🇳XSHE.300204ChinaHealthcare
CNÂ¥19.44CNYdown -0.02 (-0.1%)ClosedEnd of day4:18 PM
PriceCNÂ¥19.44-0.02 (-0.1%)
Profile
- Healthcare
- Biotechnology
- China
Identity
- Exchange
- Shenzhen Stock Exchange . XSHE
- Type
- Stock
- ISIN
- CNE100001237
- CUSIP
- Not reported
Company
- Employees
- 484
- Headquarters
- Beijing, China
- Website
- https://www.staidson.com
Market
- Shares outstanding
- 477.8M
- Market cap
- CNÂ¥9.29B
Highlights
- Market cap
- CNÂ¥9.3B
- EPS LTM
- -CNÂ¥0.35calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -55.93calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- CNÂ¥268.02M-28.94%down year on year
- Net income
- -CNÂ¥166.06M+33.28%up year on year
- Gross margin
- 78.38%-4.32%down year on year
- Free cash flow
- -CNÂ¥129.73M+21.81%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.